Class Action Sought For Pre-Term Drug Makena As Ineffective, Overpriced

Mealey's (November 21, 2019, 10:44 AM EST) -- SYRACUSE, N.Y. — Two women on Nov. 12 filed a New York state class action complaint against the manufacturer of the pre-term pregnancy prevention drug Makena, arguing that the injectable drug is ineffective and overpriced (Teresa Faughnan, et al. v. AMAG, Inc., No. 19-1394, N.D. N.Y.)....

Attached Documents

Related Sections